ROYCE & ASSOCIATES LP - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 88 filers reported holding TRINITY BIOTECH PLC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q2 2017$1,093,000
-37.5%
182,142
-37.9%
0.01%
-36.4%
Q1 2017$1,748,000
-13.9%
293,3300.0%0.01%
-15.4%
Q4 2016$2,030,000
-65.0%
293,330
-33.2%
0.01%
-65.8%
Q3 2016$5,805,000
-34.3%
439,130
-43.6%
0.04%
-34.5%
Q2 2016$8,835,000
-5.2%
779,098
-2.5%
0.06%
-1.7%
Q1 2016$9,317,000
+12.8%
799,098
+13.7%
0.06%
+20.4%
Q4 2015$8,263,000
+21.2%
702,598
+17.9%
0.05%
+36.1%
Q3 2015$6,819,000
-27.3%
596,098
+14.8%
0.04%
-10.0%
Q2 2015$9,379,000
+31.3%
519,298
+40.0%
0.04%
+48.1%
Q1 2015$7,142,000
+11.5%
371,000
+1.4%
0.03%
+22.7%
Q4 2014$6,405,000
+32.3%
365,792
+38.0%
0.02%
+37.5%
Q3 2014$4,842,000
-20.7%
265,0000.0%0.02%
-11.1%
Q2 2014$6,103,000
-9.7%
265,000
-5.0%
0.02%
-10.0%
Q1 2014$6,758,000
-16.5%
278,924
-13.4%
0.02%
-13.0%
Q4 2013$8,095,000
+8.8%
322,000
-5.8%
0.02%
+4.5%
Q3 2013$7,442,000
+31.5%
342,000
+1.8%
0.02%
+29.4%
Q2 2013$5,658,000335,8000.02%
Other shareholders
TRINITY BIOTECH PLC shareholders Q1 2015
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders